Compounds and methods for inhibiting growth of a protozoan parasite. Methods of treating a protozoan parasite infection in a subject by administering a therapeutically effective amount of a compound as disclosed herein. The compounds and methods can be used to inhibit growth of protozoan parasites such as
Trypanosoma brucei, Trypanosoma cruzi, Leishmania
spp., and
Plasmodium
spp.
NAPHTHYRIDINONE ANALOGS AS MGLUR5 POSITIVE ALLOSTERIC MODULATORS
申请人:Conn P. Jeffrey
公开号:US20120172391A1
公开(公告)日:2012-07-05
In one aspect, the invention relates to naphthyridinone analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
[EN] BRUTON'S TYROSINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA TYROSINE KINASE DE BRUTON
申请人:SUNNYLIFE PHARMA INC
公开号:WO2017127371A1
公开(公告)日:2017-07-27
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I).
Bruton's酪氨酸激酶(Btk)抑制剂具有以下化学式(I)。
Method For Rapidly Evaluating Performance Of Short Interfering RNA With Novel Chemical Modifications
申请人:Butora Gabor
公开号:US20120252027A1
公开(公告)日:2012-10-04
It is an object of the instant invention to provide a method for the rapid evaluation of novel sugar modifications to be used in siRNA synthesis including the rapid evaluation of chemical modification patterns within the siRNA to effectuate increased stability and ultimately increased efficacy of a siRNA therapeutic. It is a further object of the instant invention to provide novel nucleosides useful for siRNA therapy.
METHOD FOR RAPIDLY EVALUATING PERFORMANCE OF SHORT INTERFERING RNA WITH NOVEL CHEMICAL MODIFICATIONS
申请人:SIRNA THERAPEUTICS, INC.
公开号:US20150132761A1
公开(公告)日:2015-05-14
It is an object of the instant invention to provide a method for the rapid evaluation of novel sugar modifications to be used in siRNA synthesis including the rapid evaluation of chemical modification patterns within the siRNA to effectuate increased stability and ultimately increased efficacy of a siRNA therapeutic. It is a further object of the instant invention to provide novel nucleosides useful for siRNA therapy.